Escitalopram for Agitation in Alzheimer's Disease (NCT03108846)

🧪 Interventions in This Study

• Escitalopram (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (29 Sites)

Showing the first 25 of 29 sites.

• Banner Sun Health Research Institute — Sun City, Arizona
• Biomedical Research Foundation — Little Rock, Arkansas
• University of Arkansas for Medical Sciences — Little Rock, Arkansas
• University of California Los Angeles/VA Greater Los Angeles Healthcare System — Los Angeles, California
• University of Southern California Keck School of Medicine Memory and Aging Center — Los Angeles, California
• Miami Jewish Health Systems — Miami, Florida
• Kansas School of Medicine-Wichita Center for Clinical Research — Wichita, Kansas
• Maryland VA Health Care System — Baltimore, Maryland
• Johns Hopkins University School of Medicine, Bayview Medical Center — Baltimore, Maryland
• Alzheimer Disease Center — Quincy, Massachusetts
• Hackensack Meridian Health — Hackensack, New Jersey
• Columbia University — New York, New York
• University of Rochester Medical Center — Rochester, New York
• Ohio State University — Columbus, Ohio
• Abington Neurological Associates, Ltd — Abington, Pennsylvania
• Alzheimer Disease Research Center; University of Pittsburgh — Pittsburgh, Pennsylvania
• Roper St. Francis Healthcare — Charleston, South Carolina
• Baylor AT&T Memory Center — Dallas, Texas
• UT Health San Antonio — San Antonio, Texas
• University of Virginia Adult Neurology — Charlottesville, Virginia
• Eastern Virginia Medical School — Norfolk, Virginia
• Northwest Clinical Research Center — Bellevue, Washington
• University of Calgary and Foothills Medical Centre — Calgary, Alberta
• Lawson Health Research Institute/Parkwood Institute — London, Ontario
• Neuropsychopharmacology Research Group, Sunnybrook — Toronto, Ontario

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Dementia

• A Virtual Reality at Home Intervention for People Living With Dementia — Toronto, Ontario
• Caregiver Bootcamp — Atlanta, Georgia
• A Spanish-language Caregiver-Enabled Care Program — Carlsbad, California
• The Sunnybrook Dementia Study — Toronto, Ontario
• Palliative Care for Patients With Dementia — New York, New York
• Cognitive Health Awareness Program in Surgical Patients — Toronto, Ontario

Explore by condition: All Dementia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.